Tumor doubling times in metastatic malignant melanoma of the uvea: Tumor progression before and after treatment

Ophthalmology

Volumn 107, Issue 8, 2000, Pages 1443-1449

  Eskelin, Sebastian ^a   Pyrhönen, Seppo ^a,b   Summanen, Paula ^a   Hahka Kemppinen, Marjo ^a   Kivelä, Tero ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b TURKU UNIVERSITY HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; DACARBAZINE; INTERFERON; LOMUSTINE; VINCRISTINE;

ARTICLE; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER IMMUNOTHERAPY; CANCER SIZE; CLINICAL ARTICLE; FEMALE; HUMAN; MALE; METASTASIS; OUTCOMES RESEARCH; PRIORITY JOURNAL; UVEA MELANOMA;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BRACHYTHERAPY; COMBINED MODALITY THERAPY; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; IODINE RADIOISOTOPES; LIVER FUNCTION TESTS; LIVER NEOPLASMS; MALE; MELANOMA; REGISTRIES; RETROSPECTIVE STUDIES; RUTHENIUM RADIOISOTOPES; SURVIVAL RATE; TIME FACTORS; UVEAL NEOPLASMS;

EID: 0033769530     PISSN: 01616420     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0161-6420(00)00182-2     Document Type: Article

References (36)

1. Uveal melanoma. Growth rate and prognosis
2. Choroidal melanoma. Enucleation or observation? A new approach
3. Uveal melanoma: Updated considerations on current management modalities
4. Tumor doubling time and prognostic assessment of patients with primary lung cancer
5. Uveal melanoma: Therapeutic consequences of doubling times and irradiation results; A review
6. Comparison of uveal melanoma growth rates with mitotic index and mortality
7. Rate of growth of intraabdominal metastases from colorectal cancer
8. Observations on growth rates of human tumors
9. Cell cycling and prognosis in uveal melanoma
10. Growth analysis of pulmonary metastases from salivary gland tumors
11. Actual doubling time values of pulmonary metastases from malignant melanoma
12. Metastatic choroidal melanoma
13. Malignant melanomas of the uvea in Denmark 1943-1952. A clinical, histopathological, and prognostic study
14. Metastatic uveal melanoma. Pretherapy serum liver enzyme and liver scan abnormalities
15. The prevalence and location of metastases from ocular melanoma: Imaging study in 110 patients
16. Current management of posterior uveal melanoma
17. Growth rates and doubling times of posterior uveal melanomas
18. Inferred natural history of uveal melanoma
19. A promising interferon plus four-drug chemotherapy regimen for metastatic melanoma
20. BOLD+interferon in the treatment of metastatic uveal melanoma: First report of active systemic therapy
21. A biomathematical approach to clinical rumor growth
22. Small (1.5 cm or less) liver metastases: US-guided biopsy
23. Enucleation vs cobalt plaque radiotherapy for malignant melanomas of the choroid and ciliary body
24. Das Aderhautmelanom. Eine retrospektive radomisierte Vergleichsstudie Ruthenium-Bestrahlung vs Enukleation
25. Impact of enucleation versus plaque radiotherapy in the management of juxtapapillary choroidal melanoma on patient survival
26. Microvascular loops and networks as prognostic indicators in choroidal and ciliary body melanomas
27. Biologic distinctions between cure and time to death in 2892 patients with intraocular melanoma
28. Prognostic factors following enucleation of 111 uveal melanomas
29. A prognostic factor study of disease-free interval and survival following enucleation for uveal melanoma
30. Uveal melanoma: Location, size, cell type, and enucleation as risk factors in metastasis
31. Screening for metastatic malignant melanoma of the uvea revisited
32. Treatment of metastatic uveal melanoma: Review and recommendations
33. Prognosis and treatment of disseminated uveal melanoma
34. Treatment of uveal melanoma metastatic to the liver: A review of the M.D. Anderson Cancer Center experience and prognostic factors
35. Treatment of ocular melanoma metastatic to the liver by hepatic arterial chemotherapy